問卷

TPIDB > Principal Investigator

Principal Investigator


Hualien Tzu Chi Hospital (在職)

Division of General Surgery

更新時間:2023-09-19

陳言丞
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

6Cases

2022-10-01 - 2024-03-11

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Terminated5Sites

2021-09-01 - 2027-12-31

Phase II

Active
A Phase II Study to Evaluate the Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma (HCC) Patients After Curative Treatment
  • Condition/Disease

    Hepatocellular Carcinoma

  • Test Drug

    ATL

Participate Sites
14Sites

Not yet recruiting5Sites

Recruiting9Sites

2022-06-01 - 2026-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2022-10-01 - 2024-03-11

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2020-02-01 - 2026-02-01

Others

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Not yet recruiting2Sites

2022-06-01 - 2026-12-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Not yet recruiting1Sites

Recruiting5Sites